Literature DB >> 31508179

HIGH-SENSITIVITY C-REACTIVE PROTEIN, POSSIBLE BIOMARKER FOR DEPRESSION IN ELDERLY POPULATION.

T Purnichi1, V P Matei2,3, R Grigoras4, C R Banu5, M C Pirlog1.   

Abstract

CONTEXT: The immune system has an important role in the etiology of depression, through the pro-inflammatory cytokines and acute phase protein mechanisms. In elderly people, frequent association between depression and medical conditions leads to a difficult psychiatric diagnosis, becoming necessary to determine a specific biological marker for this category of population. C-Reactive Protein (CRP) did not prove to have a high level of validity, but higher levels of high-sensitivity C-Reactive Protein (hs-CRP) were found to be associated both with cardiovascular disease and depressive disorder, through a bidirectional relationship.
OBJECTIVES: To investigate the possible association between a major depressive episode and levels of inflammatory markers among a population of elderly. SUBJECTS AND METHODS: A prospective study on a sample of 82 individuals aged over 65 years, who presented for laboratory evaluations in an outpatient setting. They were recorded socio-demographic and clinical data; depression and anxiety were assessed using the Hospital Anxiety and Depression Scale. Blood samples were collected and analyzed according to the protocol of the study.
RESULTS: Anxiety, identified in 57 persons, was not statistically significant correlated with the levels of inflammatory markers. For depressive disorder (37 subjects), both CRP and hs-CRP were significantly higher, with an almost medium effect size.
CONCLUSIONS: The high levels of CRP and hs-CRP are associated with the presence of depression in elderly patients, but not with the anxiety. Further and complex studies need to validate these findings on this group of age.

Entities:  

Keywords:  biomarker; depression; elderly

Year:  2019        PMID: 31508179      PMCID: PMC6711655          DOI: 10.4183/aeb.2019.215

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  37 in total

1.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

Authors:  Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

Review 2.  Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes.

Authors:  John C Pickup
Journal:  Diabetes Care       Date:  2004-03       Impact factor: 19.112

3.  Cytokine production and treatment response in major depressive disorder.

Authors:  S Lanquillon; J C Krieg; U Bening-Abu-Shach; H Vedder
Journal:  Neuropsychopharmacology       Date:  2000-04       Impact factor: 7.853

4.  Life stress, mood disturbance, and elevated interleukin-6 in healthy older women.

Authors:  S K Lutgendorf; L Garand; K C Buckwalter; T T Reimer; S Y Hong; D M Lubaroff
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1999-09       Impact factor: 6.053

5.  Clinical efficacy of an automated high-sensitivity C-reactive protein assay.

Authors:  N Rifai; R P Tracy; P M Ridker
Journal:  Clin Chem       Date:  1999-12       Impact factor: 8.327

6.  Cytokine-associated emotional and cognitive disturbances in humans.

Authors:  A Reichenberg; R Yirmiya; A Schuld; T Kraus; M Haack; A Morag; T Pollmächer
Journal:  Arch Gen Psychiatry       Date:  2001-05

Review 7.  The validity of the Hospital Anxiety and Depression Scale. An updated literature review.

Authors:  Ingvar Bjelland; Alv A Dahl; Tone Tangen Haug; Dag Neckelmann
Journal:  J Psychosom Res       Date:  2002-02       Impact factor: 3.006

8.  Pathways linking depression, adiposity, and inflammatory markers in healthy young adults.

Authors:  Gregory E Miller; Kenneth E Freedland; Robert M Carney; Cinnamon A Stetler; William A Banks
Journal:  Brain Behav Immun       Date:  2003-08       Impact factor: 7.217

9.  Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women.

Authors:  A Steptoe; S R Kunz-Ebrecht; N Owen
Journal:  Psychol Med       Date:  2003-05       Impact factor: 7.723

10.  The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women.

Authors:  Kenneth S Kendler; Carol A Prescott; John Myers; Michael C Neale
Journal:  Arch Gen Psychiatry       Date:  2003-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.